Replies to post #14145 on Mymetics Corp (MYMX)

[Work Harder]

ChAd Pfs-IMX313 will either be administered alone or with MVA Pfs25-IMX313 in a prime-boost regime

Group 1 will receive one dose of ChAd63 Pfs25-IMX313

Healthy volunteers will be recruited in Oxford and Southampton, England.

NIHR Wellcome Trust Clinical Research Facility

https://clinicaltrials.gov/ct2/show/NCT02532049

Responsible Party:

University of Oxford

Not sure if or how this is all tied in but maybe mgnt will clue us in someday

Final Report Summary - MULTIMALVAX (A Multi-Stage Malaria Vaccine)

The third member is the Université Pierre et Marie Curie

https://cordis.europa.eu/project/rcn/105361/reporting/en

UNIVERSITE PARIS DESCARTES — PARIS 5 whose registered office is at 12, rue de l’Ecole de Médecine, 75270 Paris cedex 07, France, represented by Mr Bruno Varet, Administrateur Provisoire, duly authorised for the purposes hereof; - Hereinafter referred to as “UPD

http://filings.irdirect.net/data/927761/000095015208001236/l30222ae8vk.pdf

Milan Paris Oxford so must have been Morgan B in there

[bow-tie]

Malaria vaccine - Mymetics
Drug Name: "malaria mymetics"

Newly adjuvanted vaccines in children: no safety concerns

[Work Harder]

First link

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150591319

So this thing goes all the way back to 2008-02-19 as does the evolution of RGP41

If Kempers pulls this off

& we know we are due Malaria test results second half of 2019

Then HH will be the first to sing Kempers praises

LOL

Heck, I'll kiss his arse

LMAO

Just a lil more detail would make me happy

Gone for the weekend soon